Editors' Note: This article was revised to correct references to the Cigna/Catamaran deal
Catamaran at a Glance:
Market Cap: $9.08 billion
Headquarters: Chicago, IL
Ticker Symbol: NASDAQ (CTRX): TSX (CCT)
Shares Outstanding: 206.30 million
Price per share (12/15/13): $45.48
Catamaran Corporation is a leading provider of pharmacy benefit management ("PBM") services and healthcare information technology ("HCIT") solutions to the healthcare industry. The company's product offerings and solutions combine a wide range of applications and PBM services designed to assist its customers in reducing the cost and managing the complexity of their prescription drug programs. Catamaran's customers include many of the largest organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups,...
Only subscribers can access this article, which is part of the PRO research library covering 3,575 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: